HB 10922

House·20th Congress·Filed Aug 24, 2026

An Act Modernizing the Food and Drug Administration by Imposing Enforceable Processing Timelines with Automatic Approval for Low-Risk Applications, Giving Permanent Statutory Footing to the Regulatory Reliance Pathways, Eliminating the Application Backlog and Preventing Its Recurrence, Mandating Full Digitalization, Strengthening Testing and Human Resource Capacity, Amending for the Purpose Pertinent Provisions of Republic Act No. 9711, and Appropriating Funds Therefor

In plain language

The Bilis‑Gamot Act would speed up the Food and Drug Administration’s approval of medicines and other health products by setting firm deadlines, automatically approving low‑risk applications that miss those deadlines, and giving permanent legal status to fast‑track pathways that rely on approvals from trusted foreign regulators. It also requires the FDA to go fully digital, clear the current backlog of over 18,000 pending applications within 18 months, and strengthen its labs and staff, with an initial ₱1 billion‑s

HealthGovernment AdministrationScience, Technology and Innovation

Automated summary by BatasWatch. It may miss nuance — read the bill text before citing it.

Author · Representative

Elmer V. CatulposReceipts →

Official sources

Similar in what they’d do, filed by any lawmaker.

HB 7438· Filed Jan 27, 2026
An Act Streamlining Access to Investigational Drugs, Biologics, and Medical Devices for Patients with Life-Threatening or Seriously Debilitating Conditions, Establishing the Expanded Access and Right to Try Framework, and for Other Purposes
Pending with the Committee on HEALTH since 2026-02-02Rep. Adrian E. Salceda
HB 8429· Filed Mar 11, 2026
An Act Simplifying the Documentary for Accessing Assistance Requirements Government Financial and for Other Purposes
Pending with the Committee on SOCIAL SERVICES since 2026-03-17Rep. Charisse Anne C. Hernandez
HB 6317· Filed Nov 24, 2025
An Act Authorizing the Director General of the Food and Drug Administration to Issue Emergency Use Authorization, Further Amending Republic Act No. 3720, Otherwise Known as the "Food, Drug, and Cosmetic Act," as Amended by Republic Act No. 9711, O?herwise Known as the "Food and Drug Administration (Fda) Act of 2009"
Pending with the Committee on HEALTH since 2025-11-26Rep. Keith Micah "Atty. Mike" D.l. Tan
HB 8755· Filed Mar 24, 2026
An Act Strengthening the Regulation of Online Transactions Involving Health Products, Expanding the Powers of the Food and Drug Administration Under Republic Act No. 9711, and Enhancing Republic Act No. 11967 (Internet Transactions Act), Imposing Liability on Digital Platforms, and for Other Purposes
Pending with the Committee on TRADE AND INDUSTRY since 2026-05-13Rep. Eric L. Olivarez
HB 3868· Filed Aug 20, 2025
An Act Increasing Access to Cancer and Related Care Medicines by Mandating an Automatic or Expedited Licensing and Registration Process of Antineoplastic Drugs Sourced Overseas, While Ensuring Their Availability at Affordable Prices, Appropriating Funds Therefor, Amending for the Purpose Republic Act No. 11215, Otherwise Known as "National Integrated Cancer Control Act"
Pending with the Committee on HEALTH since 2025-08-27Rep. Stephen James T. Tan

Spot something wrong?

HB10922 · Sources: BatasWatch

In plain language

Author · Representative

Official sources

Related bills · 20th Congress

Author · Representative

Related bills · 20th Congress